Date | Insider | Price | Amount |
---|---|---|---|
4-2-2024 Insider Buy |
GILEAD SCIENCES, INC. >10% Owner |
$0.76 CAGR » |
$368,790.00 485,250 shares |
12-10-2021 Insider Buy |
Bain Capital Life Sciences Investors, LLC >10% Owner |
$9.66 CAGR » |
$410,161.39 42,469 shares |
10-26-2021 Insider Buy |
Impact Medicine Fund LP Sv7 >10% Owner |
$16.00 CAGR » |
$10,000,000.00 625,000 shares |
10-26-2021 Insider Buy |
BAY CITY CAPITAL LLC >10% Owner |
$16.00 CAGR » |
$5,000,000.00 312,500 shares |
10-26-2021 Insider Buy |
Atlas Venture Fund XI, L.P. >10% Owner |
$16.00 CAGR » |
$3,000,000.00 187,500 shares |
10-26-2021 Insider Buy |
James E. Flynn >10% Owner |
$16.00 CAGR » |
$12,400,000.00 775,000 shares |
10-26-2021 Insider Buy |
RiverVest Venture Fund IV, L.P. >10% Owner |
$16.00 CAGR » |
$4,000,000.00 250,000 shares |
10-26-2021 Insider Buy |
Springs Capital Management LP Rock >10% Owner |
$16.00 CAGR » |
$8,000,000.00 500,000 shares |
Also See: Institutional Holders of XLO
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/03/2024 | |
End date: | 05/03/2024 | |
Start price/share: | $1.30 | |
End price/share: | $1.18 | |
Dividends collected/share: | $0.00 | |
Total return: | -9.23% | |
Annualized Gain: | -112.31% | |
Starting investment: | $10,000.00 | |
Ending investment: | $9,077.00 | |
Years: | 0.08 |
XLO Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent XLO insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding XLO
Free XLO Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |